C0042291||Valproic acid
C2755962||neural differentiation
C0086418||human
C0032043||placenta
C1257975||mesenchymal stem cells
C1257975||Mesenchymal stem cells
C1257975||Mesenchymal stem cells
C0005516||markers
C0521458||ectodermal
C2610414||transdifferentiation
C1257975||Mesenchymal stem cells
C0694695||human placental tissue
C0694695||P
C1257975||MSC
C2755962||neural differentiation
C0694695||P
C1257975||Mesenchymal stem cells
C3156550||differentiated
C1512474||histone deacetylase (HDAC) inhibitor
C0042291||valproic acid
C0042291||valproic acid
C0010454||medium
C2755962||neural differentiation potential
C0085103||neurites
C0443981||neural lineage specific markers
C0042291||valproic acid
C1257975||cells
C1156296||significantly elevated membrane potential
C0007589||cells grown in only differentiation medium
C1658579||neuronal lineage specification
C2244568||inhibition of
C0527443||bone morphogenetic protein (BMP) 2
C0530979||BMP4
C0042291||valproic acid
C2713652||HDAC2
C0042291||valproic acid
C1334032||HDAC1
C1155515||reduction in the levels of Stat3
C3894267||upregulation of Î²III tubulin
C0443981||neuronal lineage-specific marker
C1155452||Notch signalling
C0949469||decreased notch 1
C0949479||increased notch 3
C2755962||differentiation
C1658579||neuronal lineage
C0042291||valproic acid
C0694695||P
C1257975||Mesenchymal stem cells
C0027882||neural cells
C0035168||research
C0442592||clinics